Marshall Wace North America’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-29,076
Closed -$402K 1486
2020
Q2
$402K Buy
+29,076
New +$393K ﹤0.01% 961
2020
Q1
Sell
-3,889
Closed -$68K 1618
2019
Q4
$68K Buy
+3,889
New +$66.2K ﹤0.01% 1111
2019
Q2
Sell
-24,699
Closed -$432K 1636
2019
Q1
$432K Buy
+24,699
New +$452K ﹤0.01% 838
2018
Q4
Sell
-18,898
Closed -$268K 1647
2018
Q3
$268K Sell
18,898
-1,296,652
-99% -$15.2M ﹤0.01% 808
2018
Q2
$12.8M Buy
+1,315,550
New +$16.4M 0.07% 279

Other funds holding VCEL

Marshall Wace North America's VCEL Position: Q3 2020 in Review

Marshall Wace North America sold out of Vericel Corp (VCEL) in Q3 2020, closing a stake of 29,076 shares — an estimated $402K sold.

Marshall Wace North America first reported a position in VCEL in Q2 2018 and held it in 5 quarters. The position peaked at $12.8M in Q2 2018. 140 funds tracked by Wall St. Rank hold VCEL as of Q3 2020.

  • Marshall Wace North America reported no remaining Vericel Corp position as of Q3 2020 after selling out during the quarter.
  • Marshall Wace North America sold 29,076 Vericel Corp shares in Q3 2020, an estimated $402K.
  • Marshall Wace North America first reported a position in Vericel Corp in Q2 2018 and held it in 5 quarters.
  • Marshall Wace North America's Vericel Corp position peaked at $12.8M in Q2 2018.
  • 140 funds tracked by Wall St. Rank held Vericel Corp as of Q3 2020.

Based on Marshall Wace North America's 13F filing for Q3 2020, filed 16 Nov 2020.